Elevated sputum BPIFB1 levels in smokers with chronic obstructive pulmonary disease: A longitudinal study

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 309, Issue 1, 2015, Pages L17-L26

  Gao, J ^a   Ohlmeier, S ^b   Nieminen, P ^b   Toljamo, T ^c   Tiitinen, S ^d   Kanerva, T ^a   Bingle, L ^e   Araujo, B ^e   Ronty M ^a   Hoyhtya M ^d   Bingle, C D ^e   Mazur, W ^a   Pulkkinen, V ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF OULU   (Finland)

^c LAPLAND CENTRAL HOSPITAL   (Finland)

^d Medix Biochemica   (Finland)

^e UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Biomarkers; COPD; Smoking

Indexed keywords

BACTERICIDAL PERMEABILITY INCREASING PROTEIN; BACTERICIDAL PERMEABILITY INCREASING PROTEIN A1; BACTERICIDAL PERMEABILITY INCREASING PROTEIN B1; MONOCLONAL ANTIBODY; POLYCLONAL ANTIBODY; UNCLASSIFIED DRUG; AUTOANTIGEN; BPIFA1 PROTEIN, HUMAN; GLYCOPROTEIN; LPLUNC1 PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN;

ADULT; ARTICLE; BRONCHODILATATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ASSESSMENT; CLINICAL EVALUATION; COMPARATIVE STUDY; CONTROLLED STUDY; DEGLYCOSYLATION; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; GLYCOSYLATION; GOBLET CELL; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; LONGITUDINAL STUDY; LUNG FUNCTION; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; METAPLASIA; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; SMOKING; SPUTUM ANALYSIS; SPUTUM CULTURE; SPUTUM LEVEL; TWO DIMENSIONAL GEL ELECTROPHORESIS; ADVERSE EFFECTS; BIOSYNTHESIS; CHEMISTRY; LUNG; METABOLISM; MIDDLE AGED; SECRETION (PROCESS); SPUTUM;

AUTOANTIGENS; FEMALE; FORCED EXPIRATORY VOLUME; GLYCOPROTEINS; GOBLET CELLS; HUMANS; LONGITUDINAL STUDIES; LUNG; MALE; MIDDLE AGED; PHOSPHOPROTEINS; PROTEINS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; SPUTUM;

EID: 84936076784     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00082.2015     Document Type: Article

References (39)

1. Agusti A, Soriano JB. COPD as a systemic disease. COPD 5: 133–138, 2008.
2. Bingle CD, Araujo B, Wallace WA, Hirani N, Bingle L. What is top of the charts? BPIFB1/LPLUNC1 localises to the bronchiolised epithelium in the honeycomb cysts in UIP. Thorax 68: 1167–1168, 2013.
3. Bingle CD, Craven CJ. PLUNC: a novel family of candidate host defence proteins expressed in the upper airways and nasopharynx. Hum Mol Genet 11: 937–943, 2002.
4. Bingle CD, Wilson K, Lunn H, Barnes FA, High AS, Wallace WA, Rassl D, Campos MA, Ribeiro M, Bingle L. Human LPLUNC1 is a secreted product of goblet cells and minor glands of the respiratory and upper aerodigestive tracts. Histochem Cell Biol 133: 505–515, 2010.
5. Bingle L, Barnes FA, Cross SS, Rassl D, Wallace WA, Campos MA, Bingle CD. Differential epithelial expression of the putative innate immune molecule SPLUNC1 in cystic fibrosis. Respir Res 8: 79, 2007.
6. Bingle L, Bingle CD. Distribution of human PLUNC/BPI fold-containing (BPIF) proteins. Biochem Soc Trans 39: 1023–1027, 2011.
7. Bingle L, Cross SS, High AS, Wallace WA, Devine DA, Havard S, Campos MA, Bingle CD. SPLUNC1 (PLUNC) is expressed in glandular tissues of the respiratory tract and in lung tumours with a glandular phenotype. J Pathol 205: 491–497, 2005.
8. Bingle L, Wilson K, Musa M, Araujo B, Rassl D, Wallace WA, LeClair EE, Mauad T, Zhou Z, Mall MA, Bingle CD. Bpifb1 (Lplunc1) is upregulated in cystic fibrosis lung disease. Histochem Cell Biol 138: 749–758, 2012.
9. Britto CJ, Cohn L. Bactericidal/permeability-increasing protein fold-containing family member A1 in airway host protection and respiratory disease. Am J Respir Cell Mol Biol 52: 525–534, 2015.
10. Casado B, Ladarola P, Pannell LK, Luisetti M, Corsico A, Ansaldo E, Ferrarotti I, Boschetto P, Baraniuk JN. Protein expression in sputum of smokers and chronic obstructive pulmonary disease patients: a pilot study by CapLC-ESI-Q-TOF. J Proteome Res 6: 4615–4623, 2007.
11. Casado B, Pannell LK, Iadarola P, Baraniuk JN. Identification of human nasal mucous proteins using proteomics. Proteomics 5: 2949-2959, 2005.
12. Di YP, Harper R, Zhao YH, Pahlavan N, Finkbeiner W, Wu R. Molecular cloning and characterization of spurt, a human novel gene that is retinoic acid-inducible and encodes a secretory protein specific in upper respiratory tracts. J Biol Chem 278: 1165-1173, 2003.
13. Glare EM, Divjak M, Bailey MJ, Walters EH. fj-Actin and GAPDH housekeeping gene expression in asthmatic airways is variable and not suitable for normalising mRNA levels. Thorax 57: 765-770, 2002.
14. Gray RD, MacGregor G, Noble D, Imrie M, Dewar M, Boyd AC, Innes JA, Porteous DJ, Greening AP. Sputum proteomics in inflammatory and suppurative respiratory diseases. Am J Respir Crit Care Med 178: 444–452, 2008.
15. Ishikawa N, Ohlmeier S, Salmenkivi K, Myllarniemi M, Rahman I, Mazur W, Kinnula VL. Hemoglobin alpha and beta are ubiquitous in the human lung, decline in idiopathic pulmonary fibrosis but not in COPD. Respir Res 11: 123, 2010.
16. Iwamoto H, Gao J, Pulkkinen V, Toljamo T, Nieminen P, Mazur W. Soluble receptor for advanced glycation end-products and progression of airway disease. BMC Pulm Med 14: 68, 2014.
17. Lee EJ, In KH, Kim JH, Lee SY, Shin C, Shim JJ, Kang KH, Yoo SH, Kim CH, Kim HK, Lee SH, Uhm CS. Proteomic analysis in lung tissue of smokers and COPD patients. Chest 135: 344-352, 2009.
18. Lee TH, Jang AS, Park JS, Kim TH, Choi YS, Shin HR, Park SW, Uh ST, Choi JS, Kim YH, Kim Y, Kim S, Chung IY, Jeong SH, Park CS. Elevation of S100 calcium binding protein A9 in sputum of neutrophilic inflammation in severe uncontrolled asthma. Ann Allergy Asthma Immunol 111: 268-U116, 2013.
19. Louhelainen N, Rytila P, Haahtela T, Kinnula VL, Djukanovic R. Persistence of oxidant and protease burden in the airways after smoking cessation. BMC Pulm Med 9: 25, 2009.
20. Mazur W, Toljamo T, Ohlmeier S, Vuopala K, Nieminen P, Ko-bayashi H, Kinnula VL. Elevation of surfactant protein A in plasma and sputum in cigarette smokers. Eur Respir J 38: 277-284, 2011.
21. Merkel D, Rist W, Seither P, Weith A, Lenter MC. Proteomic study of human bronchoalveolar lavage fluids from smokers with chronic obstructive pulmonary disease by combining surface-enhanced laser desorption/ ionization-mass spectrometry profiling with mass spectrometric protein identification. Proteomics 5: 2972-2980, 2005.
22. Nicholas B, Skipp P, Mould R, Rennard S, Davies DE, O’Connor CD, Djukanovic R. Shotgun proteomic analysis of human-induced sputum. Proteomics 6: 4390-4401, 2006.
23. Nicholas BL, Skipp P, Barton S, Singh D, Bagmane D, Mould R, Angco G, Ward J, Guha-Niyogi B, Wilson S, Howarth P, Davies DE, Rennard S, O’Connor CD, Djukanovic R. Identification of lipocalin and apolipoprotein A1 as biomarkers of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 181: 1049-1060, 2010.
24. Ohlmeier S, Mazur W, Linja-aho A, Louhelainen N, Ronty M, Toljamo T, Bergmann U, Kinnula VL. Sputum proteomics identifies elevated PIGR levels in smokers and mild-to-moderate COPD. J Proteome Res 11: 599-608, 2012.
25. Ohlmeier S, Mazur W, Salmenkivi K, Myllarniemi M, Bergmann U, Kinnula VL. Proteomic studies on receptor for advanced glycation end product variants in idiopathic pulmonary fibrosis and chronic obstructive pulmonary disease. Proteomics Clin Appl 4: 97-105, 2010.
26. Ohlmeler S, Vuolanto M, Toljamo T, Vuopala K, Salmenkivi K, Myllarniemi M, Kinnula VL. Proteomics of human lung tissue identifies surfactant protein A as a marker of chronic obstructive pulmonary disease. J Proteome Res 7: 5125–5132, 2008.
27. Paggiaro PL, Chanez P, Holz O, Ind PW, Djukanovic R, Maestrelli P, Sterk PJ. Sputum induction. Eur Respir J 20: 3s–8s, 2002.
28. Pastor MD, Nogal A, Molina-Pinelo S, Melendez R, Salinas A, GonzalezDelaPena M, Martin-Juan J, Corral J, Garcia-Carbonero R, Carnero A, Paz-Ares L. Identification of proteomic signatures associated with lung cancer and COPD. J Proteomics 89: 227–237, 2013.
29. Rabe KF, Beghe B, Luppi F, Fabbri LM. Update in chronic obstructive pulmonary disease 2006. Am J Respir Crit Care Med 175: 1222–1232, 2007.
30. Rutgers SR, Postma DS, ten Hacken NH, Kauffman HF, van Der Mark TW, Koeter GH, Timens W. Ongoing airway inflammation in patients with COPD who do not currently smoke. Thorax 55: 12–18, 2000.
31. Rytila P, Rehn T, Ilumets H, Rouhos A, Sovijarvi A, Myllarniemi M, Kinnula VL. Increased oxidative stress in asymptomatic current chronic smokers and GOLD stage 0 COPD. Respir Res 7: 2006.
32. Saferali A, Obeidat M, Berube JC, Lamontagne M, Bosse Y, Lavio-lette M, Hao K, Nickle DC, Timens W, Sin DD, Postma DS, Strug LJ, Gallins PJ, Pare PD, Bingle CD, Sandford AJ. Polymorphisms associated with expression of BPIFA1/BPIFB1 and lung disease severity in cystic fibrosis. Am J Respir Cell Mol Biol 2015 Jan 9. [Epub ahead of print].
33. Steiling K, Kadar AY, Bergerat A, Flanigon J, Sridhar S, Shah V, Ahmad QR, Brody JS, Lenburg ME, Steffen M, Spira A. Comparison of proteomic and transcriptomic profiles in the bronchial airway epithelium of current and never smokers. PLoS One 4: e5043, 2009.
34. Toljamo T, Hamari A, Sotkasiira M, Nieminen P. Clinical characteristics of COPD syndrome: a 6-year follow-up study of adult smokers. Ann Med. In press.
35. Toljamo T, Kaukonen M, Nieminen P, Kinnula VL. Early detection of COPD combined with individualized counselling for smoking cessation: a two-year prospective study. Scand J Prim Health Care 28: 41–46, 2010.
36. Tu C, Mammen MJ, Li J, Shen X, Jiang X, Hu Q, Wang J, Sethi S, Qu J. Large-scale, ion-current-based proteomics investigation of bronchoal-veolar lavage fluid in chronic obstructive pulmonary disease patients. J Proteome Res 13: 627–639, 2014.
37. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, Anzueto A, Barnes PJ, Fabbri LM, Martinez FJ, Nishimura M, Stockley RA, Sin DD, Rodriguez-Roisin R. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187: 347–365, 2013.
38. Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Fukuchi Y, Jenkins C, Rodriguez-Roisin R, van Weel C, Zielinski J; Global Initiative for Chronic Obstructive Lung Disease. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 176: 532–55, 2007.
39. Wu J, Kobayashi M, Sousa EA, Liu W, Cai J, Goldman SJ, Dorner AJ, Projan SJ, Kavuru MS, Qiu YC, Thomassen MJ. Differential proteomic analysis of bronchoalveolar lavage fluid in asthmatics following segmental antigen challenge. Mol Cell Proteomics 4: 1251–1264, 2005.